Physician profile
Cathy M Russo
NPI 1992790364
$2,234.26
in general payments reported to CMS, 2019-2025
16 companies · $456 in 2025
The $456 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $214 · 2021: $230 · 2022: $314 · 2023: $220 · 2024: $457 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,132.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $773.07 | 2019-2025 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $335.86 | 2020-2025 | Entyvio, Eohilia, Gattex |
| Janssen Biotech, INC. | $200.76 | 2024-2025 | Tremfya |
| Abbvie INC. | $166.32 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $143.60 | 2019-2022 | |
| Aimmune Therapeutics, INC. | $131.09 | 2024-2025 | Zenpep |
| Phathom Pharmaceuticals, INC. | $105.56 | 2024-2025 | Voquezna |
| Braintree Laboratories, INC. | $78.06 | 2019-2023 | Sutab |
| Redhill Biopharma INC. | $72.08 | 2022-2023 | |
| Nestle Healthcare Nutrition INC. | $61.60 | 2021-2023 | |
| Ferring Pharmaceuticals INC. | $54.81 | 2019-2020 | |
| Ardelyx, INC. | $30.64 | 2022-2023 | Ibsrela |
| Shire North American Group INC | $27.80 | 2019 | |
| Boston Scientific Corporation | $18.49 | 2024 | |
| Lilly USA, LLC | $18.25 | 2025 | Omvoh |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $16.27 | 2025 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cathy Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.